Lasa Supergenerics

Lasa Supergenerics Limited is an Indian company established in 2016 that operates within the healthcare sector, focusing on both human and animal health products. Their core business revolves around the research, manufacturing, and marketing of these products, encompassing a broad spectrum of activities within the pharmaceutical and veterinary industries.

A significant portion of Lasa's business centers on the production and sale of Active Pharmaceutical Ingredients (APIs). These APIs form the foundational components of many medications and are crucial for the manufacturing of both human and animal drugs. Their API portfolio is diverse, including key substances such as fenbendazole, albendazole, closantel, and various other compounds used in treating parasitic infections and other health conditions in animals. They also produce APIs for human use, illustrating their reach across both sectors.

Beyond APIs, Lasa Supergenerics Limited manufactures and supplies animal feed ingredients. This expands their role in the animal health market, offering essential components for complete animal nutrition solutions. The inclusion of calcium iodate as a notable product highlights their commitment to providing crucial nutritional supplements for livestock.

Furthermore, the company produces and provides reagents for therapeutic applications. These reagents, such as potassium iodide, are important components used in various medical and veterinary treatments. This further diversifies their product offerings and strengthens their position within the healthcare sector.

Finally, a key aspect of Lasa's business model involves exporting its products. This international reach demonstrates their capacity to compete on a global scale and indicates a significant contribution to the international pharmaceutical and veterinary supplies market. Their operations encompass the entire chain, from research and development to manufacturing, marketing, and distribution both domestically and internationally.